Living life with Carrera, ‘no regrets’

Article

Targeting a fun-loving audience, the latest Carrera campaign continues with its “AFTER ALL, NO REGRETS” headline and showcases a series of characters in exhilarating life situations. The campaign went live in September.

Parsippany, NJ-Targeting a fun-loving audience, the latest Carrera campaign continues with its “AFTER ALL, NO REGRETS” headline and showcases a series of characters in exhilarating life situations. The campaign went live in September.

The campaign features characters that experience exciting and captivating moments with intensity and determination, accompanied at all times by Carrera eyewear as an inseparable companion. Each character seizes every opportunity to have fun and actively seeks out new challenges, new people, and new sensations. The campaign aims to identify an ideal list of the top 10 things to do in life, with no regrets.

For more articles in this issue of InDispensable, click here.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Susana Marcos, PhD, outlines a presentation she gave at ARVO 2025 on a unique utilization of optical coherence tomography.
Karl Stonecipher ASCRS 2025
AnnMarie Hipsley, DPT, PhD, at ASCRS 2025
Neda Shamie, MD; Selina McGee, OD, FAAO, Dipl ABO; and Jacob Lang, OD, FAAO; provided their insights during CIME 2025 on May 4.
At ARVO 2025, Mark Bullimore, MCOptom, PhD, emphasized the need for more accurate, condition-specific tools in evaluating myopic eye growth and treatment efficacy.
Dr Luke Lindsell discusses retinal therapy and geographic atrophy at Controversies in Modern Eye Care 2025
Neda Shamie, MD, speaks on cataract and refractive surgery at CIME 2025.
Dr Selina McGee shares thoughts on pharmacological presbyopia correction at Controversies in Modern Eye Care 2025
Paul Hammond, OD, FAAO, presents a poster at ARVO 2025 on the creation of a conversion factor between 2 OCT devices to monitor glaucoma progression
© 2025 MJH Life Sciences

All rights reserved.